Delivery Order SPE2DR25D6028-SPE2DR26FASCN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,271.71 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100. This firm fixed-price contract, with an ultimate completion date of August 20, 2025, represents a competitively awarded, non-set-aside procurement executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg tablets (100 count) on October 28, 2025, with a ceiling value of $1,029.76 and an ultimate completion date of October 29, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $1,907.65 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg tablets (100-count units). The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, utilizes firm fixed-price pricing with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $1,513.10, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets (100 count). This is a firm fixed price, non-competitive delivery order with an ultimate completion date of October 31, 2025, issued on October 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 units, with a ceiling value of $1,396.35 and an ultimate completion date of December 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,257.11 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine 5mg tablets (100-count units) under a firm fixed price contract. The award was made on November 5, 2025, with an ultimate completion date of the same date, and represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,498.56 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) on November 5, 2025, with completion scheduled for November 6, 2025. This non-competitive, firm fixed-price delivery order was fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, representing a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,884.59 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg tablets (100 count) on April 24, 2025, with completion scheduled for April 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $3,805.34 to AmerisourceBergen Drug Corp for Dextroamphetamine 10mg in quantities of 100 units. This is a firm fixed price delivery order with an ultimate completion date of November 25, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,144.26 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 15 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 29, 2025. The delivery order was issued on July 28, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASCNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,952.64 to AmerisourceBergen Drug Corp for Dextroamphetamine 20mg tablets (100 count) on November 26, 2025, with completion targeted for December 24, 2025. This competitive award, made without set-aside provisions, represents a firm fixed-price delivery order for pharmaceutical supply to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement extending through December 2026 that enables comprehensive global pharmaceutical support to military healthcare systems. As a major pharmaceutical distributor serving federal medical supply chains, AmerisourceBergen maintains an extensive portfolio of controlled and non-controlled medications, vaccines, and medical supplies across multiple therapeutic domains. The company's federal contracting demonstrates consistent capability to fulfill competitive procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles supporting military readiness and veteran care.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 11/25/25 |